tiprankstipranks
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8

Compare BioMarin Pharmaceutical (BM8) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BioMarin Pharmaceutical
€48.63
€9.27B
32.67
-22.64%
13 Buy
3 Hold
0 Sell
Strong Buy
Jazz Pharmaceuticals
$186.95
$11.51B
12.74
47.86%
12 Buy
0 Hold
0 Sell
Strong Buy
PTC Therapeutics
$67.77
$5.61B
8.85
40.11%
8 Buy
4 Hold
0 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$22.45
$2.17B
-3.94
-36.53%
17 Buy
2 Hold
0 Sell
Strong Buy
Summit Therapeutics
$19.38
$15.03B
-5.28%
8 Buy
2 Hold
0 Sell
Strong Buy
Immunovant
$24.50
$4.99B
-10.43
49.21%
10 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BM8
BioMarin Pharmaceutical
48.63
-12.21
-20.07%
JAZZ
Jazz Pharmaceuticals
186.95
76.91
69.89%
PTCT
PTC Therapeutics
67.77
24.53
56.73%
RARE
Ultragenyx Pharmaceutical
22.45
-9.98
-30.77%
SMMT
Summit Therapeutics
19.38
2.02
11.64%
IMVT
Immunovant
24.50
9.92
68.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts